l-asparaginase Injection, lyophilized 500 IU, 10000 IU

Established in 1992, this manufacturer employs approximately 892 individuals and specializes in pharmaceutical finished dosage forms, active pharmaceutical ingredients (APIs), and drug intermediates. As a CTD dossier owner and manufacturer, it holds GMP approvals from multiple countries, ensuring compliance with international quality standards. The manufacturer operates advanced production lines for metered dose inhalers, dry powder inhalers, nebulization solutions, and tablets, adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in over 25 countries worldwide. With a focus on innovation, the manufacturer is a CTD dossier owner and manufacturer, dedicated to developing high-quality pharmaceutical solutions.